News
Nvidia stock has pulled back in the past four consecutive days. It has slumped from the all-time high of $243 to the current $230...
Hi, what are you looking for?
On Oct. 28, before earnings, I covered Morgan Stanley‘s preview of Shopify: sales were booming, and a holiday test was coming. And I find...
Paying for healthcare in America is complicated enough without having to figure out why the same prescription can cost more from one refill to...
For years, Nike (NKE) was my default whenever I needed a new pair of tennis shoes. But recently, I switched to On Cloud (ONON)...
More than 2 million shares in one of the world’s most valuable publicly traded companies are heading to children’s investment accounts, raising a tax...
Nvidia stock has pulled back in the past four consecutive days. It has slumped from the all-time high of $243 to the current $230...
Amazon is in talks to acquire Decart, a fast-growing artificial intelligence (AI) company. According to the WSJ, Amazon is planning to buy the company...
A higher close is not a reversal. Oracle (NYSE: ORCL) finished Friday 9 October 2026 at $141.40, up 4.21 percent from Thursday’s Nasdaq close...
The obvious reading is that a 240 MW campus in India offset CoreWeave’s OpenAI-linked drop. It did not. The campus was already public, and...
The obvious reading of Thursday’s tape is that chip stocks are the Nasdaq, so a softer OpenAI revenue figure and a lagging Composite are...
The obvious reading is that Thursday’s drop priced Broadcom’s exposure to OpenAI and Anthropic at once. It did not. The drop was about OpenAI....
A US import license is not a diesel cargo, and the cargo President Trump named is not a day of American use. The arrangement...
Updated 12 October 2026. Brent crude traded around $104 a barrel on Monday 12 October, after giving up a weekend jump to $105.48. Trading...
Investment managers are spending considerably more on AI-enabled research tools without materially increasing their overall research budgets, according to a new survey from Substantive...
Crumbl faces two massive problems. First, the chain sells a pricey indulgence customers don’t actually need. Second, millions of Americans are taking GLP-1 drugs...